Prostatic acid phosphatase
Prostatic acid phosphatase (18-26) is a synthetic peptide fragment derived from the amino acid sequence spanning residues 18 to 26 of the human prostatic acid phosphatase (PAP) protein. As a defined peptide epitope, it represents a segment of a key enzyme involved in prostate physiology and associated biochemical pathways. The peptide's unique sequence and structural features make it a valuable tool for researchers investigating protein-protein interactions, immune recognition, and enzymatic function within the context of prostatic biology and related molecular mechanisms. Its utility extends across biochemical, immunological, and analytical applications, offering precise control in experimental systems that require well-characterized peptide reagents.
Epitope mapping: The 18-26 peptide fragment serves as a critical resource for epitope mapping studies aimed at identifying the specific regions of PAP recognized by antibodies or T-cell receptors. By employing this peptide in immunoassays such as ELISA or peptide microarrays, researchers can dissect the fine specificity of immune responses to PAP, facilitating the development of sensitive detection methods and the characterization of antibody binding sites. This capability is particularly valuable in the context of prostate research, where understanding immune recognition of PAP is essential for both basic and translational investigations.
Antibody production and validation: Synthetic peptides corresponding to defined protein regions, such as PAP (18-26), are routinely utilized as immunogens for the generation of polyclonal or monoclonal antibodies. Incorporating this peptide into immunization protocols enables the production of antibodies with targeted specificity to the selected epitope, supporting the development of research-grade reagents for detection, quantification, or localization of PAP in biological samples. Furthermore, the peptide serves as an essential control in antibody validation assays, ensuring the accuracy and selectivity of immunochemical tools used in proteomic studies.
Peptide-based assay development: The defined sequence and purity of the PAP (18-26) peptide allow for its integration into custom assay platforms designed to detect or quantify PAP or its immune response. As a standard or calibrator in immunoassays, the peptide provides a reproducible reference point for assay optimization and quality control. Its application in multiplexed or high-throughput screening formats supports the advancement of analytical techniques in prostate research, enabling robust and sensitive measurement of protein or antibody levels in complex biological matrices.
T-cell response studies: The PAP (18-26) peptide can be leveraged in cellular immunology experiments to evaluate T-cell reactivity against specific PAP epitopes. By pulsing antigen-presenting cells with this peptide, investigators can assess T-cell activation, cytokine production, or cytotoxicity in vitro, thereby elucidating the cellular immune landscape associated with PAP. Such studies contribute to a deeper understanding of antigen processing, presentation, and immune surveillance mechanisms relevant to prostate tissue biology and immunological research.
Protein interaction research: As a discrete segment of the prostatic acid phosphatase protein, the 18-26 peptide offers a focused probe for exploring protein-peptide and protein-ligand interactions. Researchers may employ the peptide in binding assays, structural studies, or surface plasmon resonance experiments to characterize the molecular determinants of PAP's interactions with other biomolecules. This approach enables detailed investigation of binding affinities, conformational preferences, and sequence-specific recognition events, providing valuable insights into the functional roles of PAP in cellular and molecular contexts.
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More